The number of visually impaired people in this world amounts to 342 million (more than the entire population of the United States), a number that is shared by both ends of life, the young and the old. Of this number, 23.7 million are U.S. adults experiencing some sort of vision loss. Among those visually impaired, 70% are unemployed and are 3 times more likely to end up in long term care, all because their vision is compromised. A number of startups are developing vision enhancement devices that use technologies like artificial intelligence (AI) and augmented reality to provide the masses with an alternative to deteriorating eyesight and blindness. Here are 6 examples.
A growth-driven and strategic executive, Peter Coffaro commands more than 20 years of progressive management success within the medical device industry. As a District Sales Manager for Stryker Orthopaedics, Peter was responsible for managing and directing a regional sales force to achieve sales and profit goals within the Rocky Mountain region. Previously, he was the Director of Sales & Marketing for Amp Orthopedics. In this role, Peter was responsible for planning, developing, and leading all sales and marketing initiatives. Peter is a former orthopedic distributor in the Pacific Northwest. He has also worked with DePuy Orthopaedics as well as Zimmer, and held positions in sales, sales training, and sales management. Peter has an extensive background in organizational development, business development, sales management, negotiating and P&L management. Peter holds a B.S. degree in Biology from Northern Illinois University.
John Jameson might not have believed in miracles a year ago, but breakthroughs in modern science have made certain that he does now. The Tatum, Texas man had been blind for more than 40 years after […]
When Deona Duke woke up from a medically-induced coma to begin recovering from burns that covered almost a third of her body, one of her treatments was hurling snowballs at penguins. The 13-year-old was set […]
As an industry, healthcare is notoriously resistant to change, and when it comes to clinical information, this limitation is felt most acutely. It’s been the Achilles heel of the industry, but now real foundational change is […]
Be the first to comment